Abstract
Single-tracer methoxyisobutylisonitrile (MIBI) imaging is considered to be a sensitive method for the localization of abnormal parathyroid glands. The aims of this study were to determine which of the analytical techniques described for this method — visual comparison of early (15-min) and late (120-min) images, use of time-activity curves (TACs) generated on regions of interest and factor analysis of dynamic structures (FADS) — corresponds best with surgical findings, and to ascertain the potential overall contribution of presurgical scintigraphy. Fifty-five patients were studied, 34 of whom presented with primary hyperparathyroidism (HPT) and 21 with secondary HPT. After a 925 MBq injection of technetium-99m MIBI, a 40-min dynamic acquisition was performed and static images were acquired at 5, 20, 40 and 120 min using a gamma camera equipped with a pinhole collimator. The dynamic series were submitted to FADS, an attractive non-operator-dependent technique, and TACs were generated on regions of interest after the visual comparison of early and 120-minute images (15′–120′). The presumed localizations of abnormal glands were compared with a sketch drawn by the surgeon. Sensitivity was defined as the percentage of truepositive localizations and was 84.4%, 74% and 65% in adenoma and 76%, 66.6% and 45% in hyperplasia for 15′–120′, FADS and TACs, respectively. Surgical accuracy, i.e. the percentage of patients accurately and completely described, was 72%, 56% and 59% in adenoma and 53%, 30% and 22% in hyperplasia for 15′–120′, FADS and TACs, respectively. The visual comparison method scored best in all cases. FADS was found to be sensitive in cases of adenoma but was handicapped by more false-positive localizations. TACs were particular inefficient in hyperplasia. With respect to the detection of adenomas, we found a relationship between the gland weight and scintigraphic positivity. This dependence on gland weight was not found in hyperplasia. The poorer results obtained with all techniques for surgical accuracy can be explained by the need for a complete scintigraphic description of all pathological glands found by the surgeon in a patient. This study demonstrates that the 15′–120′ visual comparison method is more efficient and less cumbersome than TAC or the attractive FADS technique. However, it was less efficient than neck exploration by an experienced surgeon. Therefore, in our institution, scintigraphic studies are now only requested in selected cases of HPT, usually primary HPT and cases undergoing re-operation.
Similar content being viewed by others
References
Coakley AJ, Kettle AG, Wells CP, et al. Technetium-99m-sestamibi — a new agent for parathyroid imaging.Nucl Med Commun 1989; 10: 791–794.
O'Doherty MJ, Kettle AG, Wells CP, et al. Parathyroid imaging with technetium 99m-sestamibi: preoperative localization and tissue uptake studies.J Nucl Med 1992; 33: 313–318.
Geatti O, Shapiro B, Orsolon PG, et al. Localization parathyroid enlargement experience with technetium-99m methoxyisobutylisonitrile and thallium-201 scintigraphy, ultrasonography and computed tomography.J Nucl Med 1994; 21: 17–22.
Casara D, Rubello G, Saladini G, et al. Preoperative imaging of pathologic parathyroid glands (PG): comparison of99mTc-MIBI scintigraphy,201Tl scintigraphy, neck echography (NE), computed tomography (CT) and magnetic resonance (MR) [abstract].Eur J Nucl Med 1992; 19: 684.
Taillefer S, Boucher Y, Potvin C, Lambert R. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study).J Nucl Med 1992; 33: 1801–1807.
Billotey C, Aurengo A, Najean Y, Sarfati E, Moretti JL, Toubert ME, Rain JD. Identifying abnormal parathyroid glands in the thyroid uptake area using technetium-99m-sestamibi and factor analysis of dynamic structures.J Nucl Med 1994; 35: 1631–1636.
McBiles M, Lambert AT, Cote MG, Yong Kim S. Sestamibi parathyroid imaging.Semin Nucl Med 1995; 25: 221–234.
Taillefer R.99mTc sestamibi parathyroid imaging.Nucl Med Annu 1995: 51–77.
Carvalho PA, Chiu ML, Kronauge JF, et al. Subcellular distribution and analysis of technetium-99m-MIBI in isolated perfused rat hearts.J Nucl Med 1992; 33: 1516–1521.
Backus M, Piwnica-Worms D, Hockett D, et al. Microprobe analysis of technetium-MIBI in heart cells: calculation of mitochondrial membrane potential.Am J Physiol 1993; 265: 178–187.
Crane P, Laliberté R, Hemingway S, et al. Effect of mitochrondrial viability and metabolism on technetium-99m-sestamibi myocardial retention.Eur J Nucl Med 1993; 20: 20–25.
Foldes I, Levay A, Stotz G. Comparative scanning of thyroid nodules with technetium-99m-pertechnetate and technetium-99m-methoxyisobutylisonitrile.Eur J Nucl Med 1993; 20: 330–333.
Stauderherz A, Telfeyan D, Steiner E, et al. Scintigraphic pitfalls in giant parathyroid glands.J Nucl Med 1995; 36: 467–469.
Di Paola R, Bazin JP, Aubry F, et al. Handling of dynamic sequence in nuclear medicine.IEEE Trans Nucl Sci 1982; NS-29: 1310–1321.
Adalet I, Hawkins T, Clarck F, Wilkinson R. Thallium-technetium-subtraction scintigraphy in secondary hyperparathyroidism.Eur J Nucl Med 1994; 21: 509–513.
Doppman J. Reoperative parathyroid surgery: localization procedures, parathyroid surgery.Prog Surg 1986; 18: 117–136.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Blocklet, D., Martin, P., Schoutens, A. et al. Presurgical localization of abnormal parathyroid glands using a single injection of technetium-99m methoxyisobutylisonitrile: Comparison of different techniques including factor analysis of dynamic structures. Eur J Nucl Med 24, 46–51 (1997). https://doi.org/10.1007/BF01728308
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF01728308